Last reviewed · How we verify

ear pain or itching from other earaches — Treatment Landscape & Competitive Intelligence

ear pain or itching from other earaches (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating ear pain or itching from other earaches, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Hylands Naturals Earache Drops BELLADONNA Hyland's Inc.

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. Hyland's Inc. · 1 drug in ear pain or itching from other earaches

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in ear pain or itching from other earaches:

Cite this brief

Drug Landscape (2026). ear pain or itching from other earaches — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/ear-pain-or-itching-from-other-earaches. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing